BREEDLOVE ROBERT CHARLES (Principal Accounting Officer) reported 1 transaction at PHATHOM PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/23/2026ACC: 0001193125-26-021164
Officer· Principal Accounting Officer
Since Feb 2026
-776.00
Net shares
Net seller
$10.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
776.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−776.00
Price / share
$13.61
Trade value
$10.56K
% of position
1.6%
1/21/2026
47.84K→47.07K
Total
Net shares
−776.00
Net value
-$10.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2026 | F · Tax Withholding | −776.00 | $13.61 | $10.56K | 1.6% | 47.84K | 47.07K |
| Total | −776.00 | -$10.56K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned6.95K
Total
6.95K indirect6.95K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.95K | Indirect |
| Total | 6.95K | 6.95K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported